Ratings Bushveld Minerals Limited

Equities

BMN

GG00B4TM3943

Market Closed - London S.E. Other stock markets 16:35:08 01/05/2024 BST			5-day change	1st Jan Change
0.7 ^GBX	-1.41%		+6.06%	-66.67%

04-29	Transcript : Bushveld Minerals Limited, Q1 2024 Operating Results Call, Apr 29, 2024
04-23	EARNINGS AND TRADING: Graft Polymer extends loan; ASA profit down 30%	AN

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

The stock, which is currently worth 2023 to 0.6 times its sales, is clearly overvalued in comparison with peers.
Sales forecast by analysts have been recently revised upwards.
For several months, analysts have been revising their EPS estimates roughly upwards.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

The company has insufficient levels of profitability.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the past year, analysts have significantly revised downwards their profit estimates.
Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Uranium

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
BUSHVELD MINERALS LIMITED	-66.67%	19.3M		C-
URANIUM ENERGY CORP.	+6.72%	2.73B		B
CGN MINING COMPANY LIMITED	+21.51%	1.99B		-
YELLOW CAKE PLC	+8.33%	1.75B	-	-
BOSS ENERGY LIMITED	+27.67%	1.31B	-	D
CENTRUS ENERGY CORP.	-20.86%	687M		D+
URANIUM ROYALTY CORP.	-10.11%	282M		-
ELEVATE URANIUM LTD	+12.36%	97.15M	-	-
GOVIEX URANIUM INC.	-43.33%	50.26M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes